Drug development in Alzheimer's disease: the path to 2025

Jeffrey Cummings, Paul S. Aisen, Bruno DuBois, Lutz Froelich, Clifford R., Jr. Jack, Roy W. Jones, John C. Morris, Joel Raskin, Sherie A. Dowsett, Philip Scheltens

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number39
JournalAlzheimer's Research & Therapy
Volume8
DOIs
Publication statusPublished - 20 Sep 2016

Cite this

Cummings, J., Aisen, P. S., DuBois, B., Froelich, L., Jack, C. R. . J., Jones, R. W., ... Scheltens, P. (2016). Drug development in Alzheimer's disease: the path to 2025. Alzheimer's Research & Therapy, 8, [39]. https://doi.org/10.1186/s13195-016-0207-9